Related Experiment Video

Updated: Mar 10, 2026

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K

Ocular microparticle formulations for 6-month delivery of anti-VEGF

Kinam Park1

  • 1Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|December 15, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

12.0K
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
07:12

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

2.8K

Related Experiment Videos

Last Updated: Mar 10, 2026

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

12.0K
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
07:12

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

2.8K

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

152
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
152
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70

Articles linked to this work by shared authors, journal, and citation graph.

Multiscale Dissolution Simulation of Particles from a Tablet in Dissolution Apparatus by Coupling Discrete Element with Lattice Boltzmann Methods.

Pharmaceutical research·2026

Evaluation of a Novel Flexible Cage System for C5-C6 Fixation: A Finite Element Study Against Conventional ACDF Implants.

Bioengineering (Basel, Switzerland)·2026

Compacted solid implant formulations for long-term buprenorphine delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026

Recent advances in polymer-based drug delivery systems for atopic dermatitis: enhancing therapeutic efficacy and outcomes.

Materials today. Bio·2025

Challenges and innovations in long-acting injectable formulations: can formulation design space be rationalized?

The Journal of pharmacy and pharmacology·2025

Long-Acting injectable buprenorphine PLGA microparticle formulation.

International journal of pharmaceutics·2025

Engineered cryo-shocked tumor cells recruit T cells for lung cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Synergistic RNA therapy for scar reduction: co-delivery mRNA and siRNA attenuates MDA5/RIG-I activation to enhance anti-fibrotic efficacy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Integrating tumor microenvironment modulation with nanocarrier engineering for enhanced tumor-targeted delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026

Single-component immunomodulatory hyaluronic acid hydrogel patch for accelerated chronic wound healing application.

Journal of controlled release : official journal of the Controlled Release Society·2026

mRNA vaccines for glioblastoma: integrating multiomics and nanomedicine to overcome spatiotemporal heterogeneity.

Journal of controlled release : official journal of the Controlled Release Society·2026

A coordination-assembled ferric nanoenzyme enables spatiotemporal radical storm for amplifying chemodynamic immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us